Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

gsk_boronia_australia

GlaxoSmithKline opens new £56 million facility in Hertfordshire

April 19, 2016
Manufacturing and Production Andrew Witty, GSK, GlaxoSmithKline, Sir Andrew Witty, ellipta, facility, george freeman, inhalers, manufacturing, new, respiratory, ware

GlaxoSmithKline has opened a new £56 million manufacturing facility in Hertfordshire, South-East England. The facility in Ware will create 150 …

News
albumedix

Albumedix technology extends dosing interval in Behring haemophilia B drug

March 22, 2016
Manufacturing and Production, Research and Development Albumedix, GSK, Idelvion, Novozymes, VELTIS, haemophilia B

Novozymes subsidiary Albumedix has scored another big pharma tie-up for its albumin-based half-life extension technology VELTIS, which this time is …

News

Sir Andrew Witty announces decision to step down as CEO of GSK

March 17, 2016
Medical Communications, Research and Development Andrew Witty, GSK, GlaxoSmithKline, Neil Woodford, Sir Andrew Witty, Witty, gsk break up, gsk split, retirement, steps down

Sir Andrew Witty has announced his decision to retire from his role as chief executive officer of pharmaceutical giant, GlaxoSmithKline …

News
gsk_sign_good

GSK’s asthma drug meets primary goal in safety study for children

March 17, 2016
Research and Development Advair Diskus, GSK, asthma, drug trial

GlaxoSmithKline (LSE: GSK) said on Thursday its asthma drug met the primary end point in a second study for children. …

News
gsk_l_rgb-web

GSK establish cell and gene therapy collaboration with Miltenyi Biotec

March 16, 2016
Medical Communications, Research and Development GSK, GlaxoSmithKline, cell and gene therapy, collaboration, miltenyi biotec

GlaxoSmithKline (NYSE:GSK) has announced a strategic collaboration with Miltenyi Biotec that will see GSK’s expertise in developing cell and gene …

News
five_prime_therapeutics_scientist

GSK terminates Five Prime Therapeutics mesothelioma collaboration

March 14, 2016
Research and Development, Sales and Marketing Five Prime Therapeutics, GSK, mesothelioma

GSK is to back out of a licensing deal with California-based Five Prime Therapeutics to develop a mesothelioma drug. Announcing …

News

MSF challenges Pfizer’s pneumonia vaccine patent in India

March 11, 2016
Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, Prevnar 13, pneumonia vaccine

The charity Médecins Sans Frontières (MSF) has formally opposed Pfizer’s bid to obtain a patent for the pneumonia vaccine PCV13, …

News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

Two-drug combo shown to significantly shrink breast cancer in days

March 10, 2016
Medical Communications, Research and Development GSK, Herceptin, Novartis, Roche, Tyverb

Results of a clinical trial have revealed that Novartis’ Tyverb (lapatinib), in combination with Roche’s Herceptin (trastuzumab), can significantly shrink …

News

Genmab ends ofatumumab trials for autoimmune conditions; to focus on multiple sclerosis

March 9, 2016
Research and Development Arzerra, GSK

Danish drug-company Genmab (Nasdaq Copenhagen: GEN) said it will discontinue the late-stage trials for Arzerra (ofatumumab) to develop a treatment for …

News
gsk_corp_hq_brentford_2

GSK says long-term study for Nucala backs safety profile

March 8, 2016
Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, Nucala, asthma

UK pharma major GlaxoSmithKline (LSE: GSK) said its asthma drug, Nucala (mepolizumab) showed a similar safety profile in a long-term …

News
viiv_healthcare

ViiV completes BMS HIV pipeline purchase

February 23, 2016
Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, GSK, HIV, Pfizer, Shionogi, ViiV

ViiV Healthcare has completed its previously-announced acquisition of Bristol-Myers Squibb’s late-stage HIV R&D assets and its portfolio of preclinical and …

News
Adaptimmune

GSK and Adaptimmune expand R&D collaboration

February 3, 2016
Research and Development Adaptimmune, GSK, T-cell therapy, immunotherapy, liposarcoma, rare cancer, sarcoma

Adaptimmune Therapeutics and GlaxoSmithKline have expanded the terms of their strategic collaboration agreement, to run clinical trials of Adaptimmune’s potential …

News
Mosquito image

GSK and Sanofi considering developing Zika vaccine

January 26, 2016
Manufacturing and Production GSK, Sanofi, World Health Organisation, Zika virus, microcephaly

Pharma companies Sanofi and GSK are reviewing the possibility of using their respective inoculation technologies to develop a vaccine for …

News
Researcher

Big pharma and UK universities launch £40m innovation fund

January 25, 2016
Research and Development, Sales and Marketing Apollo, AstraZeneca, GSK, GlaxoSmithKline, Johnson & Johson, UCL, University College London, University of Cambridge, collaboration, imperial college london, joint venture

A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …

News
6123892769_1befc31f38_o

GSK ‘in discussions’ over $1 billion tech deal with Qualcomm

January 21, 2016
Medical Communications GSK, beyond the pill, digital pharma, joint venture, qualcomm

GlaxoSmithKline and telecoms giant Qualcomm are reportedly discussing a joint venture agreement worth as much as $1 billion, as the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025